How rollout has been planned

The South African Health Products Regulatory Authority (Sahpra) has approved the Astra-Zeneca vaccine for emergency use in the country over a week ago.

covid-19 patients will require two doses of covishield vaccine, up to four to six weeks apart. The first batch arrives in the country today.
covid-19 patients will require two doses of covishield vaccine, up to four to six weeks apart. The first batch arrives in the country today. (SHWE PAW MYA TIN)

As SA receives the first batch of Covid-19 vaccines today, the Department of Health said the first phase will aim to vaccinate all of the country’s front-line healthcare workers across the spectrum – from surgeons to cleaners.

They will be treated in the most part with the COVISHIELD vaccine, which was developed by AstraZeneca and uses viral vector technology to build immunity, the department said.

The entry of the vaccine into the body stimulates the immune system to produce antibodies to destroy the virus. When the individual contracts the coronavirus, their immune system recognises the virus and is able to destroy it.

The department said the effectiveness of the COVISHIELD vaccine against the virus is rated between 62% and 90%.

Patients will require two doses, up to four to six weeks apart. The government has developed an Electronic Vaccine Data system to streamline the vaccine registration and rollout process. It will allow authorities to capture all relevant data associated with the administration of the vaccine – data that will be stored on a safe database that complies with international security standards.

People can register for the vaccine online and will receive a message from the system allocating a date and venue where they can receive their first dose as well as a dedicated vaccination code.

Once the vaccine is administered, the system will record that one has taken the first dose and will notify that person with details of when they may return for a second jab.

Experts say SA needs to vaccinate 67% of the adult population, about 40m people, to achieve herd immunity.

Of these, 7.1m have medical aids and 32,9m do not and most rely on statefacilities.

The department said once a clinical trial shows that a Covid-19 vaccine is safe and effective, a series of independent regulators and reviewers will closely study the findings before manufacturing and distribution is approved.

Dr Clare Cutland, a scientific coordinator at the Wits African Leadership in Vaccinology Expertise consortium, said vaccines like the Astra-Zeneca,

said although one dose was considered effective, the second dose has a booster effect that helps the body build immunity against the virus.

The doses could be given weeks or months apart. Twelve  weeks are recommended by the ministerial advisory committee.

Sahpra chairperson Prof Helen Rees said it independently evaluates and verifies vaccines efficacy in the country before approving it using high standards that were never compromised even in an emergency situation similar to what SA is facing.


Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Comment icon